Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Fawsitt CG., Vickerman P., Cooke G., Welton NJ., Barnes E., Ball J., Brainard D., Burgess G., Cooke G., Dillon J., Foster G., Gore C., Guha N., Halford R., Whitby K., Holmes C., Howe A., Hudson E., Hutchinson S., Irving W., Khakoo S., Klenerman P., Martin N., Massetto B., Mbisa T., McHutchison J., McKeating J., McLauchlan J., Miners A., Murray A., Shaw P., Simmonds P., Spencer C., Thomson E., Vickerman P., Zitzmann N.

DOI

10.1016/j.jval.2018.12.011

Type

Journal article

Publisher

Elsevier BV

Publication Date

2019-06-01T00:00:00+00:00

Volume

22

Pages

693 - 703

Total pages

10

Permalink More information Close